Funding for CRC/TRR 288 extended

The SFB/TRR 288 „Elastic Tuning and Response of Electronic Quantum Phases of Matter (ELASTO-Q-MAT)“ has received funding from the DFG since 2020. The researchers involved are attempting to understand and exploit new physical phenomena emerging from a particularly strong coupling between a material's elasticity and its electronic quantum phases.

In addition to Goethe University (GU) Frankfurt as the Applicant Institution, Johannes Gutenberg University (JGU) Mainz and the Karlsruhe Institute of Technology (KIT) are involved in the joint SFB/TRR 288 as Co-Applicant Institutions. Participating Institutions are the Max Planck Institute for Polymer Research in Mainz and the Max Planck Institute for Chemical Physics of Solids in Dresden. 

The DFG will provide funding of around 12.8 million euros for the SFB/TRR 288 until 2028.

Funding for new Collaborative Research Centres 

In addition to the extension of funding for the joint SFB/TRR 288, Goethe University Frankfurt and Johannes Gutenberg University Mainz successfully submitted applications for the establishment and funding of new Collaborative Research Centres. 

With the newly established SFB 1660 “Hadrons and Nuclei as Discovery Tools”, which focuses on exploring physics beyond the standard model of particle physics, the interface between hadron physics and nuclear physics and investigating nuclear astrophysics, JGU as spokesperson aims to improve the understanding of elementary particles. Other institutions involved in the new SFB are the Helmholtz Institute Mainz (HIM), Goethe University Frankfurt, University of Münster, Mount Allison University in Kanada, University of Edinburgh as well as the universities of Ljubljana, Manitoba and Silesia. Over the next four years, the newly-established CRC will receive funding of around 10.7 million euros.

CRC/TRR 379 „Neuropsychobiology of Agression: A Transdiagnostic Approach in Mental Disorders“, which consists of 20 subprojects and for which RWTH Aachen acts as the spokesperson, involves Goethe University as Co-Applicant, together with the University of Heidelberg, as well as Johannes Gutenberg University, Forschungszentrum Jülich Julius Maximilians-Universität Würzburg. The CRC/TRR aims to understand the effects of genes, molecular mechanisms, hormones and neuronal synapses on aggressive behavior and to develop corresponding therapies. The CRC/TRR will receive funding of around 16 million euros until 2028.

GU and JGU  are also involved in the newly-established SFB/TRR 387 “Functionalizing the Ubiquitin System against Cancer” (UbiQancer led by Technical University of Munich. Further participants include Julius-Maximilians-Universität Würzburg, Kiel University, Helmholtz Munich and the Max Planck Institute of Biochemistry in Martinsried. The SFB/TRR focuses on the mechanisms and effects of the ubiquitin system in the case of acute myeloid leukemia (AML) and the interaction between leukemia cells and bone marrow, with the aim of making the ubiquitin system usable in the development of therapies and developing new cancer drugs. The DFG will provide funding of around 18 million euros for the CRC/TRR until 2028.

With the Collaborative Research Centres, the DFG, as the largest research funding organization in Germany, wants to support innovative, challenging and long-term research projects within research groups. The CRC thus serve to enable the development of institutional priority area and structural development at the applicant universities and to strengthen top-level research.